Doppler de arterias uterinas y marcadores angiogénicos (sFlt-1/PlGF): futuras implicaciones para la predicción y el diagnóstico de la preeclampsia

Zhang, 2003, Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States, Hypertens Pregnancy, 22, 203, 10.1081/PRG-120021066 Catov, 2007, Risk of early or severe pre-eclampsia related to pre-existing conditions, Int J Epidemiol, 36, 412, 10.1093/ije/dyl271 Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22. Von, 2003, Subclassification of preeclampsia. Hypertens, Pregnancy, 22, 143 Sibai, 2005, Pre-eclampsia, Lancet, 365, 785, 10.1016/S0140-6736(05)71003-5 Sibai, 2003, What we have learned about preeclampsia, Semin Perinatol, 27, 239, 10.1016/S0146-0005(03)00022-3 Menzies, 2007, Instituting surveillance guidelines and adverse outcomes in preeclampsia, Obstet Gynecol, 110, 121, 10.1097/01.AOG.0000266977.26311.f0 Haddad, 2009, Expectant management in pregnancies with severe pre-eclampsia, Semin Perinatol, 33, 143, 10.1053/j.semperi.2009.02.002 Conde-Agudelo, 2008, Use of Doppler ultrasonography to predict pre-eclampsia, CMAJ, 179, 53, 10.1503/cmaj.1080039 Levine, 2004, Circulating angiogenic factors and the risk of preeclampsia, NEJM, 350, 672, 10.1056/NEJMoa031884 Aardema, 2001, Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses, Placenta, 22, 405, 10.1053/plac.2001.0676 Levine, 2005, Circulating angiogenic factors in preeclampsia, Clin Obstet Gynecol, 48, 372, 10.1097/01.grf.0000160313.82606.d7 Steinberg, 2009, Angiogenic factors and preeclampsia, Thromb Res, 123, S93, 10.1016/S0049-3848(09)70020-9 Martin, 2001, Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation, Ultrasound Obstet Gynecol, 18, 583, 10.1046/j.0960-7692.2001.00594.x Cnossen, 2008, Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis, CMAJ, 178, 701, 10.1503/cmaj.070430 Herraiz, 2009, Application of a first-trimester prediction model for pre-eclampsia based on uterine arteries and maternal history in high-risk pregnancies., Prenat Diagn, 29, 1123, 10.1002/pd.2383 Papageorghiou, 2004, The role of uterine artery Doppler in predicting adverse pregnancy outcome, Best Pract Res Clin Obstet Gynaecol, 18, 383, 10.1016/j.bpobgyn.2004.02.003 Campbell, 2005, First-trimester screening for pre-eclampsia, Ultrasound Obstet Gynecol, 26, 487, 10.1002/uog.2591 Askie, 2007, Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data, Lancet, 369, 1791, 10.1016/S0140-6736(07)60712-0 Akolekar, 2008, Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia, Ultrasound Obstet Gynecol, 32, 732, 10.1002/uog.6244 Herraiz, 2009, Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome inpregnancies at high risk of impaired placentation., Ultrasound Obstet Gynecol, 33, 518, 10.1002/uog.6366 Staboulidou, 2009, First-trimester uterine artery Doppler and serum pregnancy-associated plasma protein-a in preeclampsias and chromosomal defects, Fetal Diagn Ther, 25, 336, 10.1159/000235880 Widmer, 2007, Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review, Obstet Gynecol, 109, 168, 10.1097/01.AOG.0000249609.04831.7c Espinoza, 2007, Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor, Am J Obstet Gynecol, 196, 326.e1, 10.1016/j.ajog.2006.11.002 Stepan, 2007, Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion, Hypertension, 49, 818, 10.1161/01.HYP.0000258404.21552.a3 Crispi, 2008, Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction, Ultrasound Obstet Gynecol, 3, 303, 10.1002/uog.5184 Diab, 2008, Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry, Int J Gynaecol Obstet, 102, 146, 10.1016/j.ijgo.2008.02.016 Ghi, 2009, The prognostic role of uterine artery Doppler studies in patients with late-onset preeclampsia, Am J Obstet Gynecol, 201, 36.e1, 10.1016/j.ajog.2009.02.024 Meler, 2010, The prognostic role of uterine artery Doppler investigation in patients with severe early-onset preeclampsia, Am J Obstet Gynecol, 202, 559.e1, 10.1016/j.ajog.2010.01.048 Meler, 2010, Prognostic role of uterine artery Doppler in patients with preeclampsia, Fetal Diagn Ther, 27, 8, 10.1159/000258048 Sunderji, 2010, Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study, Am J Obstet Gynecol, 202, 40.e1, 10.1016/j.ajog.2009.07.025 Verlohren, 2010, An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia, Am J Obstet Gynecol, 202, 161.e1, 10.1016/j.ajog.2009.09.016 Masuyama, 2006, Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis, Am J Obstet Gynecol, 194, 551, 10.1016/j.ajog.2005.08.034 Qazi, 2008, Soluble Fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus, J Rheumatol, 35, 631 Young, 2010, The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome, J Matern Fetal Neonatal Med, 23, 366, 10.3109/14767050903184207 Roche Diagnostics GmbH. Elecsys Flt-1 (Package Insert). 05340519001-V1. Mannheim, Germany: Roche Diagnostics GmbH; 2008. Roche Diagnostics GmbH. Elecsys PlGF (Package Insert). 05340420001-V1. Mannheim, Germany: Roche Diagnostics GmbH; 2008. Sibai, 2003, Diagnosis and management of gestational hypertension and preeclampsia, Obstet Gynecol, 102, 181, 10.1016/S0029-7844(03)00475-7 Herraiz, 2009, Uterine artery Doppler and sFlt1 /PlGF ratio as useful tools to predict severe complications after the diagnosis of preeclampsia is confirmed, Ultrasound Obstet Gynecol, 34, 105, 10.1002/uog.6782 Gilbert, 2010, Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension, Hypertension, 55, 380, 10.1161/HYPERTENSIONAHA.109.141937